AstraZeneca’s new Healthy Heart Africa program is aimed at increasing awareness of the symptoms and risks of hypertension among vulnerable populations in Africa.
Initially launching in Kenya, the program will provide education, screening, treatment and methods to control hypertension. AstraZeneca is collaborating with non-government organizations from Kenya and other countries to offer support to local health systems in identifying and treating those with hypertension.
During 12-to-18-month long demonstration projects, different models will be tested to determine the best way to integrate hypertension care into existing health platforms,
As part of the program, the company plans to guarantee a supply of affordable hypertension medications, including calcium-channel blockers, angiotensin-converting enzyme (ACE) inhibitors and hydrochlorothiazide diuretics.
According to AstraZeneca, the African continent has the highest number of adults with hypertension, or high blood pressure. Hypertension raises patients’ risks of developing cardiovascular conditions such as heart disease or stroke. Cardiovascular disease is the leading cause of death among those 45 and older in Africa, the company noted.